The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/global-prevalence-treatment-and-prevention-hepatitis-b-virus-infection-2016
[2] http://admin.indiaenvironmentportal.org.in/category/author/polaris-observatory-collaborators
[3] http://admin.indiaenvironmentportal.org.in/category/journal/lancet-gastroenterology-hepatology-0
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/hepatitis
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/statistics
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pakistan
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/south-asia
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/global
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/china
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/diagnostic-methods
